Psilocybin

Psilocybin

Psilocybin

PY

Primary Products

$

DrugSURE® Integrated Test Cups

$

DrugSURE® Dip Tests

$

OralTox® Oral Fluid Tests

ng/ml

Cut-Off Levels

Urine Specimen: 500 ng/mL

WOD

Window of Detection Times

Urine Specimen: 1 – 3 Days

What is Psilocybin?

Psilocybin is a naturally occurring psychedelic compound found in certain species of mushrooms commonly known as “magic mushrooms.” Once ingested, psilocybin is rapidly converted by the body into psilocin, the active compound responsible for its psychoactive effects. In its natural form, psilocybin-containing mushrooms typically appear dried or fresh and may range in color from tan to brown with distinctive caps and stems; illicit forms may also appear as ground powders, capsules, or infused edibles. Users consume psilocybin recreationally for its hallucinogenic properties, including altered perception, mood shifts, and changes in consciousness. While not used medicinally in standard clinical practice today, psilocybin is under investigation in research settings for potential therapeutic applications in depression, anxiety, and addiction—but these uses remain experimental and highly regulated.

Recreational use often involves swallowing whole mushrooms, drinking them as tea, or consuming ground powder. Effects generally begin within 20–40 minutes and can last 4–6 hours. Because potency varies significantly between mushroom species and batches, users face unpredictable experiences and potential risks such as panic, paranoia, impaired judgment, and dangerous behavior during hallucinations. From a toxicology standpoint, psilocybin is challenging to detect using typical point-of-care rapid tests because it quickly metabolizes into psilocin, which requires more specialized laboratory methodologies for confirmation. As a result, most rapid POC panels do not include psilocybin, and testing is typically reserved for forensic or clinical lab settings when needed.

Effects:

  • Altered sensory perception (visual distortions, enhanced colors)

  • Mood shifts ranging from euphoria to anxiety

  • Changes in time perception and sense of reality

  • Intensified emotions and introspection

  • Hallucinations (primarily visual)

  • Nausea or gastrointestinal discomfort

  • Impaired judgment and coordination

  • Increased heart rate and blood pressure

  • Potential for panic, paranoia, or “bad trips”

  • Rare but possible persistent perceptual disturbances (HPPD)

Commons Slang Terms:

  • Magic mushrooms

  • Shrooms

  • Mushies

  • Boomers

  • Caps and stems

  • Psilocybes

  • Boomers

  • Golden tops

  • Blue meanies

  • Zoomers

Legal Status:

Psilocybin is classified as a Schedule I substance under the U.S. Controlled Substances Act, meaning it has no federally recognized medical use and a high potential for abuse. This strict legal classification limits its availability to controlled research environments and makes possession, distribution, or use illegal at the federal level, though a small number of U.S. jurisdictions have decriminalized personal possession. Despite this shifting landscape, psilocybin remains fully prohibited in virtually all workplace, government, treatment, and supervised testing programs.

For point-of-care toxicology programs, psilocybin presents a unique challenge. Because it metabolizes rapidly into psilocin and has a short detection window, psilocybin is not included on most rapid immunoassay POC drug panels. When testing is required for forensic, clinical, or legal purposes, programs rely on laboratory-based confirmatory methods such as LC-MS/MS. Testing programs must also understand that psilocybin use cannot be identified through standard multi-panel workplace tests unless specialized orders are made, and results typically cannot be obtained at the point of care.

Screening Options:

Forensic Use Only

LEGEND

 

Integrated Urine Test Cup Options Available

 

Urine Dip Card Test Options Available

 

Lab Confirmation Services Available

GET STARTED

Speak with one of our expert consultants today!

Email Us

info@ntsbiz.com

Phone

1-866-989-9300

Address

550 NW 5th St.

Boca Raton, FL 33486 

Monday - Friday

8am - 5pm

Psilocybin

Clonazepam

ng/ml

Cut-Off Levels

Urine Specimen: 100 ng/mL

WOD

Window of Detection Times

Urine Specimen: 1 – 3 Days

What is Clonazepam?

Clonazepam is a prescription benzodiazepine commonly used to treat seizure disorders, panic disorder, and certain anxiety conditions. It works by enhancing the effect of GABA, the brain’s primary inhibitory neurotransmitter, producing calming, sedative, and anti-convulsant effects. In medical form, clonazepam typically appears as small tablets or disintegrating tablets in various colors depending on dosage strength. Because of its potency and long half-life, it is carefully dosed and monitored under medical supervision.

Outside of medical use, clonazepam can be misused for its relaxing and euphoric effects, or to intensify or counteract the effects of other substances. Recreational misuse often involves taking higher-than-prescribed doses or combining it with alcohol or opioids, which significantly increases overdose risk due to respiratory depression. Illicitly, the drug may also appear as counterfeit pills meant to mimic pharmaceutical tablets, posing additional dangers due to unknown strength or adulterants.

In toxicology settings, clonazepam poses challenges because its primary metabolites—especially 7-Aminoclonazepam—are the compounds detected in urine. This requires targeted assays or confirmatory laboratory testing for accurate identification

Effects:

  • Sedation and drowsiness

  • Reduced anxiety and muscle tension

  • Impaired coordination and slowed reaction time

  • Memory impairment or difficulty concentrating

  • Dizziness or lightheadedness

  • Slurred speech

  • Dependence and withdrawal risk with repeated use

  • Respiratory depression, especially when mixed with alcohol or opioids

  • Mood changes, irritability, or emotional blunting

  • Potential for overdose when misused or taken in high doses

Commons Slang Terms:

  • K-pin / Kpin

  • Pin

  • Super Valium

  • Benzos

  • Downers

  • Chill pills

  • Tranks

Legal Status:

Clonazepam is classified as a Schedule IV controlled substance in the United States, indicating legitimate medical use but a meaningful risk of misuse or dependence. Because of this classification, benzodiazepines—including clonazepam—are routinely included in many rapid toxicology screening programs across workplace testing, treatment centers, probation programs, and clinical environments.

However, clonazepam presents a unique challenge for point-of-care tests: standard benzodiazepine immunoassays do not always reliably detect clonazepam because its major metabolite, 7-Aminoclonazepam, has weaker cross-reactivity on many rapid test strips. As a result, a person taking clonazepam may screen negative on a basic rapid test, requiring programs to rely on confirmatory laboratory testing (GC/MS or LC/MS) for accurate identification when clonazepam use is suspected or needs verification.

For testing programs, clear policies are needed regarding prescription disclosure, confirmation protocols, and interpretation of benzodiazepine screening results to ensure accuracy and compliance with regulatory expectations.

Screening Options:

Forensic Use Only

LEGEND

 

Integrated Urine Test Cup Options Available

 

Urine Dip Card Test Options Available

 

Lab Confirmation Services Available

GET STARTED

Speak with one of our expert consultants today!

Email Us

info@ntsbiz.com

Phone

1-866-989-9300

Address

550 NW 5th St.

Boca Raton, FL 33486 

Monday - Friday

8am - 5pm

Psilocybin

Xylazine

Xylazine

XYL

Primary Products

$

DrugSURE® Integrated Test Cups

$

DrugSURE® Dip Tests

$

OralTox® Oral Fluid Tests

ng/ml

Cut-Off Levels

Urine Specimen: 500, 1,000 ng/mL

WOD

Window of Detection Times

Urine Specimen: 1 – 3 Days

What is Xylazine?

Xylazine is a veterinary medication that is used as a sedative, muscle relaxant, and pain reliever in animals. It is not approved for use in humans, but it has been used illicitly as a recreational drug. Xylazine is highly potent and can cause a range of adverse effects, including respiratory depression, seizures, and coma.

Xylazine can be administered orally, injected, or inhaled. It is often used in veterinary medicine to sedate large animals such as horses and cattle. Illicit use of xylazine typically involves injecting the drug or inhaling the fumes from heated xylazine tablets. Xylazine is typically found in liquid and powder form.

Effects:

  • Sedation
  • Dizziness
  • Nausea
  • Respiratory depression (short-term)
  • Seizures, muscle twitching, and loss of consciousness (short-term)
  • Physical and psychological dependence (with long-term use)
  • Respiratory problems, liver and kidney damage, and cognitive impairment (with long-term use)
  • Mood disturbances, such as depression and anxiety (with long-term use)
  • Ulcers on the skin

Commons Slang Terms:

  • Tranq
  • Tranq Dope
  • Zombie Drug
  • Sleep-Cut
  • Philly Dope
  • Anestesia de Caballo (Spanish for Horse Anesthetic)

Legal Status:

Xylazine is a veterinary sedative approved by the U.S. Food and Drug Administration (FDA) exclusively for animal use; it is not approved for human use. At the federal level, xylazine is not classified as a controlled substance under the Controlled Substances Act. However, due to its increasing misuse in combination with illicit drugs like fentanyl, some states have taken independent action to regulate it.

In Florida, xylazine is classified as a Schedule I controlled substance, reflecting concerns over its harmful effects on humans. This classification imposes strict regulations on its possession and distribution within the state.

Nationally, the FDA has implemented measures to curb the unlawful importation of xylazine, aiming to prevent its diversion for illicit purposes while ensuring its availability for legitimate veterinary applications.

Given the evolving legal landscape surrounding xylazine, it’s essential to stay informed about both federal and state regulations, as they may change in response to emerging public health concerns.

Screening Options:

Forensic Use Only

GET STARTED

Speak with one of our expert consultants today!

Email Us

info@ntsbiz.com

Phone

1-866-989-9300

Address

550 NW 5th St.

Boca Raton, FL 33486 

Monday - Friday

8am - 5pm

Psilocybin

ETG

ETG

Ethyl Glucuronide

Primary Products

$

DrugSURE® Integrated Test Cups

$

DrugSURE® Dip Tests

$

OralTox® Oral Fluid Tests

ng/ml

Cut-Off Levels

Rapid Urine Test: 350, 500 ng/mL

WOD

Window of Detection Times

Rapid Urine Test: Up to 80 Hours

What is ETG?

EtG, or Ethyl Glucuronide, is a direct metabolite of ethanol (alcohol) that the body produces after alcohol consumption. Unlike measuring alcohol itself—which leaves the body relatively quickly—EtG remains detectable for a longer period, making it a reliable biomarker for recent alcohol use. In point-of-care rapid toxicology screening, EtG tests provide fast results at the collection site, allowing programs to identify alcohol exposure even after the effects of intoxication have subsided.

EtG testing is commonly used in workplace programs, treatment settings, court-ordered monitoring, and recovery programs where abstinence or recent use must be verified. Because EtG indicates alcohol consumption, not impairment, it helps organizations monitor compliance, assess risk, and make timely decisions. Rapid EtG screens are valued for their simplicity, quick turnaround time, and ability to detect drinking within approximately the past 24–72 hours, depending on the individual and amount consumed.

Effects:

  • Impaired Judgment 
  • Slower Reaction Time
  • Reduced Coordination 
  • Slurred Speech and Decreased Cognitive Clarity
  • Mood Changes: Lowered Inhibitions or Aggression
  • Nausea, Vomiting, and Dehydration
  • Liver Damage: Fatty Liver, Hepatitis, and Cirrhosis
  • Increased Risk of Heart Disease and High Blood Pressure
  • Cognitive Decline and Memory Problems
  • Elevated Risk of Addiction and Alcohol Use Disorder

Commons Slang Terms:

  • Booze

  • Sauce

  • Hooch

  • Hard stuff

  • Firewater

  • Juice

Legal Status:

For many private employers, there is no universal legal requirement to conduct drug or alcohol testing. However, under the Drug-Free Workplace Act of 1988, federal contractors and grantees — and many entities receiving federal funds — must commit to providing a “drug-free workplace,” which often includes drug (and sometimes alcohol) testing as part of their compliance obligations. 

For jobs regulated by the U.S. Department of Transportation (DOT) or other safety-sensitive federal industries (e.g., commercial drivers, aviation maintenance, railway workers), mandatory rules apply. For example, the DOT’s regulation known as 49 CFR Part 40 sets out when and how drug and alcohol testing must be done for safety-sensitive positions. 

The Americans with Disabilities Act (ADA) also plays a role: employers are allowed to maintain alcohol- and drug-free workplace policies, and to conduct testing, but they must respect certain protections — especially for rehabilitated individuals or those in recovery.

Screening Options:

GET STARTED

Speak with one of our expert consultants today!

Email Us

info@ntsbiz.com

Phone

1-866-989-9300

Address

550 NW 5th St.

Boca Raton, FL 33486 

Monday - Friday

8am - 5pm

Psilocybin

Phencyclidine

PCP

Phencyclidine

Primary Products

$

DrugSURE® Integrated Test Cups

$

DrugSURE® Dip Tests

$

OralTox® Oral Fluid Tests

ng/ml

Cut-Off Levels

Rapid Urine Test: 25 ng/mL

Rapid Oral Fluid Test: 3 ng/mL

WOD

Window of Detection Times

Urine Specimen: 1 – 3 Days

Oral Fluid Specimen: 48 Hours

What is PCP?

Phencyclidine (PCP) is a dissociative anesthetic originally developed in the 1950s for medical use, but it was discontinued in humans due to severe psychological side effects, including hallucinations and violent behavior. Today, PCP has no accepted medical use in people, though it remains an illicit recreational drug known for producing detachment from reality, erratic behavior, and profound changes in perception.

Illicit PCP is sold in various forms: as a crystalline powder, tablets, capsules, or a liquid (PCP dissolved in ether or similar solvents). Powder and crystal forms may appear white, yellow, or tan. It is commonly smoked by applying the liquid or powder to plant material (e.g., marijuana, mint leaves), but it may also be snorted or ingested.

Effects:

  • Intense euphoria or dissociation (“out-of-body” sensations)

  • Distorted perception of time, sound, and sight

  • Feelings of extreme strength or invulnerability

  • Agitation, aggression, or violent behavior

  • Hallucinations or psychosis

  • Numbness, loss of coordination, or blank stare

  • Elevated heart rate and blood pressure

  • Nausea, dizziness, or drooling

  • Risk of seizures or coma at high doses

  • Long-term cognitive impairment or mood disturbances

Commons Slang Terms:

  • Angel dust

  • Wet

  • Embalming fluid (street term for PCP-soaked cigarettes)

  • Rocket fuel

  • Sherm / Sherman stick

  • Ozone

  • Hog

  • Supergrass

Legal Status:

PCP is classified as a Schedule II controlled substance in the U.S., reflecting a high potential for abuse and no accepted medical use in humans. Because of its association with unpredictable behavior, aggression, and acute medical emergencies, PCP is a routine target on multi-panel drug tests used in workplaces, treatment centers, criminal justice programs, and emergency settings.

For point-of-care rapid toxicology testing programs, PCP is considered a standard analyte due to safety concerns and regulatory expectations across safety-sensitive environments. When a rapid screening device yields a presumptive positive, policies require confirmation by laboratory testing (typically GC/MS or LC/MS/MS) to differentiate true positives from rare cross-reactivity events. Programs must also maintain clear documentation, legal defensibility, and chain-of-custody procedures consistent with federal and industry standards.

Screening Options: